Press release
Anti-Hypertensive Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026
Request a Free Sample of our Anti-Hypertensive Drugs Market: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market
However, the high cost associated with anti-hypertensive drugs will turn out to be a major restraint for the growth of the anti-hypertensive market, as it has to be given to the patient for a longer period. Additionally, the low awareness and less diagnosis rate in the developing countries will also hamper the growth of the anti-hypertensive drugs market during the forecast period. Moreover, the side effects of anti-hypertensive drugs such as calcium channel blockers used during pregnancy include tachycardia, palpitations, peripheral edema, headaches, and facial flushing, which will lower the adoption of these drugs. Hence, the low adoption rate of anti-hypertensive drugs during pregnancy will majorly restrict the growth of the anti-hypertensive drug market during the forecast period.
A full Report of Anti-Hypertensive Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Anti-Hypertensive Drugs Market Segmentation
By Drug Class
• Thiazide Diuretics
• Calcium Channel Blockers
• ACE Inhibitors
• Angiotensin II Receptor Antagonists (ARBS)
• Beta Blockers
• Others
Regional Analysis
• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World
Company Profiles
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck KGaA
• Noden Pharma DAC
• Novartis International AG
• Pfizer Inc.
• Ranbaxy Laboratories Ltd.
• Renata Ltd.
• Sanofi S.A.
• Sun Pharmaceuticals LLC
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd.
• United Therapeutics Corp.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Hypertensive Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026 here
News-ID: 2158557 • Views: …
More Releases from ORION MARKET RESEARCH
Textile Market Is Expected to Exhibit Significant Growth Over 2031 / Aditya Birl …
Textile Market is projected to grow at a CAGR of 4.8% during the forecast period. The textile sector is an ever-growing market with remarkable growth prospects almost all across the globe. Favourable demographics, increasing per capita income, and a shift in preference toward branded products to drive demand for textile, globally. Superior quality and advantageous trade policies are also estimated to play an imperative role and boost textile exports.
Growth in…
Stuffed Animal & Plush Toys Market Size, Share, Trends, Demand, Segments, Leadin …
The global stuffed animal & plush toys market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2024-2031). The offline distribution channel was the largest segment in the stuffed animal & plush toys market. Offline distribution channels include gift stores, toy stores, hypermarkets, specialty stores, and others. The availability of a wide range of products in these stores is the key growth-driving factor for the segment. Moreover,…
Specialty Paper Market Update Report 2024| Industry Trends, Demand, Leading Comp …
Specialty Paper Market is projected to grow at a CAGR of over 4% during the forecast period. The key factors that drive the growth of the market include the growth in the labelling and packaging industries. The majority of paper used in the packaging and labelling industry is specialty paper. The rise in disposable and changing lifestyles along with the increased demand for specialty papers in food service, packaging, and…
Plant Protein Hydrolysates Market Is Expected to Exhibit Significant Growth Over …
Plant Protein Hydrolysates Market is estimated to grow at a considerable CAGR of % during the forecast period. Protein hydrolysates are formed by the hydrolysis of protein. Factors such as the growing demand for plant-based in the sports industry to drive the growth of the global market. Increasing demand for the product as a for infant nutrition, and as a nutraceutical is expected to drive market growth. Additionally, the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
